Top

BY Will Fitzgerald

MD Anderson-led research published in the journal Cancer is shedding light on the risk of second primary malignancies, a leading cause of long-term mortality in patients diagnosed with head and neck cancers.

The study, led by Erich M. Sturgis, M.D., professor in the Department of Head and Neck Surgery, sought to determine the impact of secondary primary cancers in relation to the original cancer site and explore potential factors...

BY Oliver Bogler, Ph.D.

I finished the most active treatment phase for male breast cancer in the first week of June, enjoyed a few weeks off...

BY Scott Merville

In glioblastoma multiforme (GBM), the most common and lethal brain tumor, lack of differentiation makes a big, and bad...

BY Scott Merville

A protein called Skp2, overexpressed in many types of cancer, for years has gotten away with promoting tumor growth and progression unhindered by effective treatments.

Hui-Kuan Lin, Ph.D., of Molecular and Cellular Oncology, has spent the last decade characterizing Skp2 and how it fuels cancer growth, and the past five years looking for a way to shut it down.

Lin teamed with Shuxing Zhang, M.D., Ph.D., in Experimental Therapeutics...